CONCLUDE: a trial COmparing the efficacy aNd safety of insulin degLUDEc and insulin glargine 300 units/mL in subjects with type 2 diabetes mellitus inadequately treated with basal insulin and oral antidiabetic drugs

Thursday, 19 September 2019, 12:00 - 13:00, Joslin Hall

Chair: T. Heise, DE

T.R. Pieber, AT: Rationale, trial design and methods

A. Philis-Tsimikas, US: Results

S. Del Prato, IT: Commentary